T 0801/06 (Cancer treatment with HSV mutant/CRUSADE) of 04.03.2009
- European Case Law Identifier
- ECLI:EP:BA:2009:T080106.20090304
- Date of decision
- 4 March 2009
- Case number
- T 0801/06
- Petition for review of
- -
- Application number
- 95927034.9
- IPC class
- A61K 35/76
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Treatment of cancer using HSV mutant
- Applicant name
- Crusade Laboratories Limited; The Wistar Institute of Anatomy and Biology
- Opponent name
- MediGene Aktiengesellschaft
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54 1973European Patent Convention Art 56 1973European Patent Convention Art 83 1973
- Keywords
- Added matter (no); sufficiency of disclosure, novelty, inventive step (yes)
- Catchword
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent as granted.